{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:11:26Z","timestamp":1758705086339,"version":"3.44.0"},"reference-count":35,"publisher":"BMJ","funder":[{"DOI":"10.13039\/100014041","name":"Alzheimer\u2019s Disease Neuroimaging Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG024904"],"award-info":[{"award-number":["U19AG024904"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,6,27]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Synapses are essential for cognitive processes, and synaptic dysfunction is a hallmark of Alzheimer\u2019s disease (AD). Beta (\u03b2)-synuclein, a homologue of alpha-synuclein, is a presynaptic phosphoprotein abundantly expressed in the brain. It has emerged as a promising candidate biomarker for synaptic dysfunction. However, its role in longitudinal clinical progression has not been fully elucidated. This study investigated the associations of serum \u03b2-synuclein levels with AD pathologies, cognitive performance and progression to dementia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We examined 474 participants from the AD Neuroimaging Initiative cohort with serum \u03b2-synuclein measurements. 233 participants also had corresponding cerebrospinal fluid (CSF) AD pathology data. Multiple linear regressions, linear mixed-effects models and Cox proportional hazards models were applied to explore the associations of serum \u03b2-synuclein level with CSF AD pathologies, cognition and dementia risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Higher serum \u03b2-synuclein levels were associated with greater CSF phosphorylated tau181 and total tau levels and lower \u03b2-amyloid (1\u201342) levels. Serum \u03b2-synuclein predicted worse baseline cognitive performance and a longitudinal decline in AD Assessment Scale-Cognitive Subscale 13, Mini-Mental State Examination and Clinical Dementia Rating-Sum of Boxes scores. Participants with higher serum \u03b2-synuclein levels showed a greater progression to dementia over 84 months compared with those with lower levels. Furthermore, even after adjusting for AD pathologies, elevated \u03b2-synuclein levels were associated with increased risk of dementia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings underscore serum \u03b2-synuclein as a promising biomarker for AD progression and cognitive decline. Further research is warranted to clarify its role in the pathogenesis of AD and validate its utility in clinical settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336234","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:20:27Z","timestamp":1758648027000},"page":"jnnp-2025-336234","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum \u03b2-synuclein predicts cognitive decline and progression to dementia"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9095-1701","authenticated-orcid":false,"given":"Nayeong","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Keimyung University School of Medicine, Daegu, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1669-6113","authenticated-orcid":false,"given":"Joon Hyung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Chungbuk National University College of Medicine, Cheongju-si, Korea (the Republic of)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"2025092310201815000_jnnp-2025-336234v1.1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00308809"},{"key":"2025092310201815000_jnnp-2025-336234v1.2","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology (ECronicon)"},{"key":"2025092310201815000_jnnp-2025-336234v1.3","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-015-0187-1","article-title":"Early neurone loss in Alzheimer\u2019s disease: cortical or subcortical?","volume":"3","author":"Arendt","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"2025092310201815000_jnnp-2025-336234v1.4","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2017.50.5.038"},{"key":"2025092310201815000_jnnp-2025-336234v1.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320155"},{"key":"2025092310201815000_jnnp-2025-336234v1.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074069"},{"key":"2025092310201815000_jnnp-2025-336234v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300410"},{"key":"2025092310201815000_jnnp-2025-336234v1.8","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-015-0124-3","article-title":"Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer\u2019s disease patients and healthy controls","volume":"7","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"2025092310201815000_jnnp-2025-336234v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.08.006"},{"key":"2025092310201815000_jnnp-2025-336234v1.10","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-9-53","article-title":"SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer\u2019s disease","volume":"9","author":"Brinkmalm","year":"2014","journal-title":"Mol Neurodegener"},{"key":"2025092310201815000_jnnp-2025-336234v1.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44374-w","article-title":"Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer\u2019s disease","volume":"15","author":"Franzmeier","year":"2024","journal-title":"Nat Commun"},{"key":"2025092310201815000_jnnp-2025-336234v1.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb10991.x"},{"key":"2025092310201815000_jnnp-2025-336234v1.13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1432-1033.1993.tb18337.x","article-title":"A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation","volume":"217","author":"Nakajo","year":"1993","journal-title":"Eur J Biochem"},{"key":"2025092310201815000_jnnp-2025-336234v1.14","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28941"},{"key":"2025092310201815000_jnnp-2025-336234v1.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324306"},{"key":"2025092310201815000_jnnp-2025-336234v1.16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13195-022-01125-1","article-title":"\u03b2-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer\u2019s disease","volume":"14","author":"Mohaupt","year":"2022","journal-title":"Alz Res Therapy"},{"key":"2025092310201815000_jnnp-2025-336234v1.17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329124"},{"key":"2025092310201815000_jnnp-2025-336234v1.18","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JPROTEOME.9B00824"},{"key":"2025092310201815000_jnnp-2025-336234v1.19","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12790"},{"key":"2025092310201815000_jnnp-2025-336234v1.20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"2025092310201815000_jnnp-2025-336234v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.01.010"},{"key":"2025092310201815000_jnnp-2025-336234v1.22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13103"},{"key":"2025092310201815000_jnnp-2025-336234v1.23","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1002\/alz.13046","article-title":"Blood \u03b2-synuclein is related to amyloid PET positivity in memory clinic patients","volume":"19","author":"Oeckl","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2025092310201815000_jnnp-2025-336234v1.24","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/brain\/awae032","article-title":"Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases","volume":"147","author":"Nilsson","year":"2024","journal-title":"Brain (Bacau)"},{"key":"2025092310201815000_jnnp-2025-336234v1.25","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.3233\/JAD-240610","article-title":"Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer\u2019s Disease","volume":"100","author":"Duits","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"2025092310201815000_jnnp-2025-336234v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00749-z"},{"key":"2025092310201815000_jnnp-2025-336234v1.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.01.015"},{"key":"2025092310201815000_jnnp-2025-336234v1.28","doi-asserted-by":"crossref","unstructured":"Zhang H , Jiang X , Ma L , et al . Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction. Front Cell Dev Biol 2022;10. doi:10.3389\/fcell.2022.964075","DOI":"10.3389\/fcell.2022.964075"},{"key":"2025092310201815000_jnnp-2025-336234v1.29","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0082-23.2023"},{"key":"2025092310201815000_jnnp-2025-336234v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.05.004"},{"key":"2025092310201815000_jnnp-2025-336234v1.31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.26360","article-title":"Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181","volume":"92","author":"Oeckl","year":"2022","journal-title":"Ann Neurol"},{"key":"2025092310201815000_jnnp-2025-336234v1.32","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.006353","article-title":"A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas","volume":"10","author":"Farrah","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"2025092310201815000_jnnp-2025-336234v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.05.012"},{"key":"2025092310201815000_jnnp-2025-336234v1.34","doi-asserted-by":"crossref","unstructured":"Nilsson J , Ashton NJ , Benedet AL , et al . Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer\u2019s disease. Alz Res Therapy 2022;14. doi:10.1186\/s13195-022-01021-8","DOI":"10.1186\/s13195-022-01021-8"},{"key":"2025092310201815000_jnnp-2025-336234v1.35","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010142","article-title":"\u03b2-Synuclein: An Enigmatic Protein with Diverse Functionality","volume":"12","author":"Hayashi","year":"2022","journal-title":"Biomolecules"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:20:31Z","timestamp":1758648031000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":35,"alternative-id":["10.1136\/jnnp-2025-336234"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336234","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"type":"print","value":"0022-3050"},{"type":"electronic","value":"1468-330X"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}